First Horizon Corporation’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

First Horizon Corporation’s Portfolio ONCT Stock Details ONCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$452K	Buy	+49	New	+$378K	0.12%	151

Other funds holding ONCT

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VHCP Management New York $93M AUM 10.04% 1-Year Est. Return

CII

CR Intrinsic Investors Stamford, Connecticut $2.67B AUM 28.43% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

First Horizon Corporation's ONCT Position: Q2 2013 in Review

First Horizon Corporation opened a new position in Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q2 2013: 49 shares worth $452K. The stake represents 0.12% of the portfolio and ranks #151 among its holdings.

63 funds tracked by Wall St. Rank hold ONCT as of Q2 2013.

First Horizon Corporation held 49 shares of Oncternal Therapeutics, Inc. Common Stock worth $452K as of Q2 2013.
Oncternal Therapeutics, Inc. Common Stock was a new First Horizon Corporation position in Q2 2013.
Oncternal Therapeutics, Inc. Common Stock made up 0.12% of First Horizon Corporation's portfolio in Q2 2013, its #151 holding.
63 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q2 2013.

Based on First Horizon Corporation's 13F filing for Q2 2013, filed 8 Aug 2013.